BioCentury
ARTICLE | Financial News

Oxagen completes venture financing

December 7, 2009 8:00 AM UTC

Oxagen Ltd., Abingdon, U.K. Business: Inflammation, Autoimmune, Endocrine Date completed: 11/20/09 Type: Venture financing Raised: £16 million ($26.5 million) Investors: Novartis Venture Funds; MPM Ca...